These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3082015

  • 1. Oral sulfonylureas for the treatment of type II diabetes: an update.
    Shank WA, Morrison AD.
    South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015
    [Abstract] [Full Text] [Related]

  • 2. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD.
    Clin Pharm; 1984 Mar; 3(5):473-85. PubMed ID: 6435940
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical pharmacology of glipizide.
    Melander A, Wåhlin-Boll E.
    Am J Med; 1983 Nov 30; 75(5B):41-5. PubMed ID: 6424440
    [Abstract] [Full Text] [Related]

  • 7. Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.
    Lebovitz HE.
    Pharmacotherapy; 1985 Nov 30; 5(2):63-77. PubMed ID: 3923454
    [Abstract] [Full Text] [Related]

  • 8. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
    Lev JD, Zeidler A, Kumar D.
    Diabetes Care; 1987 Nov 30; 10(6):679-82. PubMed ID: 3123183
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The pharmacology of sulfonylureas.
    Skillman TG, Feldman JM.
    Am J Med; 1981 Feb 30; 70(2):361-72. PubMed ID: 6781341
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide.
    De Leeuw I, De Baere H, Decraene P, Lemmens P, Verhaegen H.
    Diabetologia; 1973 Sep 30; ():364-6. PubMed ID: 4204093
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical pharmacology of sulfonylureas.
    Melander A.
    Metabolism; 1987 Feb 30; 36(2 Suppl 1):12-6. PubMed ID: 3543616
    [Abstract] [Full Text] [Related]

  • 18. Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects.
    Feldman JM.
    Pharmacotherapy; 1985 Feb 30; 5(2):43-62. PubMed ID: 3923453
    [Abstract] [Full Text] [Related]

  • 19. Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
    Sartor G, Melander A, Scherstén B, Wåhlin-Boll E.
    Acta Med Scand; 1980 Feb 30; 208(4):301-7. PubMed ID: 6778079
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.